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Reagents and anhydrous organic solvents were obtained and used without further 
purification, unless specified. Cytidine potassium thioacetate, ammonium formate and 
potassium ferricyanide were purchased from Sigma Aldrich. Sodium dihydrogen 
phosphate, N-acetyl imidazole and pyridine were purchased from Acros Organics. 
Uridine was purchased from Calbiochem. Cytidine 5'-phosphate and cytosine β-D-
arabinofuranoside 5'-monophosphate were purchased from Carbosynth. Acetic anhydride 
was purchased from Merck. Ammonia solution 28% was purchased from Fischer 
Scientific. Dowex® 50W×8 resin was purchased from Acros Organics and regenerated 
with HCl solution. Deionized water was obtained from an Elga Option 3 purification 
system. Automated flash column chromatography was carried out using a Biotage Isolera 
Four purification system and Biotage KP-C18-HS Snap Cartridge. Solution pH values 
were measured using a Mettler Toledo Seven Compact pH meter with a Mettler Toledo 
InLab semi-micro pH probe. The readings for D2O solutions are reported as pD, and 
corrected according to Covington et al.1 The readings for H2O and H2O/D2O solutions are 
reported uncorrected. NMR Spectra were recorded on a Bruker Avance III (400) equipped 
with a gradient probe or Bruker Avance III (600) spectrometer, equipped with a 
cryoprobe. Chemical shifts (δ) are reported in parts per million (ppm) relative to the 
residual solvent peak, and 1H chemical shifts relative to TMS were calibrated using the 
residual solvent peak: HOD (δH 4.75 ppm) or CDCl3 (δH 7.26 ppm). Coupling constants 
(J) are reported in Hertz (Hz). Spin multiplicities are indicated by symbols: s (singlet); d 
(doublet); t (triplet); q (quartet); ABX (geminal (AB) spin system coupled to one other 
nuclei (X)); ABXY (germinal (AB) spin system coupled to two other nuclei (X, Y)); obs. 
(obscured/coincidental signals), or a combination of these. NMR data are reported as 
follows: chemical shift (multiplicity, coupling constants (J), number of protons, nuclear 
assignment). Spectra were recorded at 298 K. Signal assignments are made by correlation 
of COSY, HMBC, HSQC and DEPT experiments. 1H NMR spectra (H2O/D2O) are 
solvent suppressed (noesygppr1d) with presaturation and spoil gradients. Infrared (IR) 
spectra were recorded with a Shimadzu 100 FTIR spectrometer. Absorption maxima are 
reported in wavenumbers (cm-1). Mass spectra were determined by the University College 
London mass spectrometry service by electrospray ionisation (ESI) using a Waters LCT 
Premier XE or Thermo Finnigan MAT 900XP instrument. UV irradiations were 
performed using a UVP Pen-Ray mercury lamp (O=254 nm) and a quartz micro-
S4 
 
photochemical reaction assembly (Ace glassware). Cooling was provided by recirculated 
water flowing through an internal quartz water jacket between the lamp and the irradiated 
solution. All solutions were sparged with Ar or N2 for 1 h prior to irradiation, and then 
continuously agitation by continuous Ar or N2 flow through a sinter glass frit at the bottom 




































D-Ribofuranosyl-2,2'-anhydrocytidine-5'-phosphate (16)  
 
Ribose aminooxazoline-5′-phosphate (ribo-3-5P; 0.046M, 760 mg, 2.99 mmol) and 
sodium dihydrogen phosphate (1.1 eq.) were dissolved in water and the solution was 
adjusted to pH 6.5 with 4M NaOH. Cyanoacetylene (5; 1M, 7 eq.) was added (to give 
total volume of 65 mL) and the solution was stirred at r.t. for 16 h then lyophilized. The 
lyophilite was purified by ion-exchange chromatography (Dowex® 50W×8, H+-form 
cation-exchange resin), eluting with water (100 mL), then 0.125M HCl (100 mL), 0.25M 
HCl (100 mL), 0.5M HCl (100 mL), 1M HCl (100 mL), 2M HCl (100 mL) and 4M HCl 
(100 mL). D-Ribofuranosyl-2,2'-anhydrocytidine-5'-phosphate (16) was obtained in 0.5–
1M HCl fractions, and was confirmed by 1H NMR. These fractions were concentrated 
and lyophilized to afford D-ribofuranosyl-2,2′-anhydrocytidine-5′-phosphate (16; 729 
mg, 80%) as a white powder.  
1H NMR (600 MHz, D2O) δ 8.19 (d, J = 7.4 Hz, 1H, (C6)-H), 6.69 (d, J = 7.4 Hz, 1H, 
(C5)-H), 6.62 (d, J = 5.4 Hz, 1H, (C1′)-H), 5.68 (dd, J = 5.6, 5.4 Hz, 1H, (C2′)-H), 4.58 
(dd, J = 8.7, 5.6 Hz, 1H, (C3′)-H), 4.28 (ABXY, J = 11.0, 5.6, 2.6 Hz, 1H, (C5′)-H). 4.07 
- 4.17 (m, 2H, (C4′)-H, (C5′′)-H). 13C NMR (151 MHz, D2O) δ 168.2 (C4), 161.6 (C2), 
141.0 (C6), 103.9 (C5), 90.9 (C1′), 84.1 (C2′), 80.1 (d, C4′), 70.1 (C3′), 63.4 (d, C5′). 31P 
NMR (162 MHz, D2O, 1H-decoupled) δ 0.49. 





D-Ribofuranosyl-2,2′-anhydrocytidine-5′-phosphate (16, 600 mg, 1.97 mmol) was 
dissolved in water (50 mL) and 4M NaOH was added to adjust the solution to pH 8.5. The 
solution pH was monitored periodically and readjusted with 4M NaOH until the pH 
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stabilized at pH 8.5. The solution was then lyophilized and the lyophilite was purified by 
ion-exchange chromatography (Dowex® 50W×8 H+-form cation-exchange resin), 
eluting with HClaq in the following concentration gradient: water (100 mL), 0.125M (100 
mL), 0.25M (100 mL), 0.5M (100 mL), 1M (100 mL), 2M (100 mL) and 4M (100 mL). 
The fractions with product were concentrated in vacuo and lyophilized to obtain α-
cytidine-5′-phosphate (α-ribo-4, 498 mg, 78%) as a white solid. 
1H NMR (600 MHz, D2O) δ 7.88 (d, J = 7.6 Hz, 1H, (C6)-H), 6.04–6.15 (m, 2H, (C1′)-
H, (C5)-H), 4.44 (t, J = 4.5 Hz, 1H, (C2′)-H), 4.31–4.36 (m, 1H, (C4′)-H), 4.28 (dd, J = 
6.3, 4.5 Hz, 1H, (C3′)-H), 4.08 (ABXY, J = 11.7, 5.6, 2.3 Hz, 1H, (C5′)-H), 3.94 (ABXY, 
J = 11.7, 6.3, 5.0 Hz, 1H, (C5′′)-H). 13C NMR (151 MHz, D2O) δ 159.8 (C4), 148.8 (C2), 
146.2 (C6), 94.4 (C5), 87.8 (C1′), 83.2 (d, C4′), 71.2 (C2′), 70.8 (C3′), 65.5 (d, C5′). 31P 
NMR (162 MHz, D2O, 1H-decoupled) δ 0.35. 
























Acetylation under prebiotic conditions of synthesised nucleotides 
 
Protocol A: Nucleotide (4; 100mM) was dissolved in D2O/H2O (1:1) and the pH adjusted 
to the desired value by addition of 4M NaOH. The solution was purged with argon for 15 
min, potassium ferricyanide (8 eq.) was added followed by potassium thioacetate (10 eq.). 
The pH was stabilised by addition of 4M HCl/NaOH and the reaction monitored by NMR 
spectroscopy. 
Protocol B: Nucleotide (4; 100mM) and N-acetyl imidazole (10 eq.) were dissolved in 
D2O/H2O (1:1). The solution pH was stabilised at the desired value through addition of 
4M HCl/NaOH and the reaction monitored by NMR spectroscopy. The product was 
purified by reverse-phase (C18) flash column chromatography (eluted at pH 4 with 
100mM NH4HCO2/MeCN 98:2 to 80:20). The fractions containing 7 were lyophilised to 
yield a white powder. 
 
Figure S1: 1H NMR spectrum (600 MHz, D2O/H2O 1:1, 1.5 – 8.5 ppm) for the acetylation 
of α-ribo-4 with thioacetate (10 eq.) and ferricyanide (8 eq.) after 1 h in D2O/H2O 1:1 at 
pH 8. 
 
Figure S2: 31P NMR spectrum (162 MHz, D2O/H2O 1:1, -20 – 20 ppm) showing 5'-
phosphate α-ribo-7 (3.78 ppm, 81%) and acetyl phosphate α-ribo-21 (-7.08 ppm, 14%) 
observed upon the reaction of α-ribo-4 with thioacetate (10 eq.) and ferricyanide (8 eq.). 
Note: partially acetylated derivatives are observed in 5% yield. 
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Figure S3: 1H NMR spectra (700 MHz, D2O/H2O 1:1, 1.5–8.5 ppm) to show the 
acetylation of α-ribo-4 with: A) 2 eq. of N-acetyl imidazole (yield α-ribo-7: 29%) ; B) 4 
eq. of N-acetyl imidazole (yield α-ribo-7: 60%); C) 6 eq. of N-acetyl imidazole (yield α-
ribo-7: 74%); D) 8 eq. of N-acetyl imidazole (yield α-ribo-7: 83%) and E) 10 eq. of N-













Nucleotide (100mM) and N-acetyl imidazole (10 eq.) were dissolved in water and the 
solution was adjusted to pH 8 by addition of 4M NaOH. The reaction mixture was 
incubated for 4 h at r.t. The solution was then adjusted to pH 4 and the product was 
immediately purified by C18 column (100mM NH4HCO2 in H2O/MeCN 98:2 to 80:20). 
The fractions with product were lyophilized to obtain white powders. 
 
2′,3′-Di-O-acetyl-α-cytidine-5′-phosphate (α-ribo-7) 
Starting from α-ribo-4 (free acid, 122 mg, 0.38 mmol), yield = 124 mg (81%) as a white 
powder. = -23.7 (c 1.0, H2O); M. p. 169–175 °C (decomp.). 1H NMR (600 MHz, 
D2O) δ 7.90 (d, J = 7.7 Hz, 1H, (C6)-H), 6.37 (d, J = 5.5 Hz, 1H, (C1′)-H), 6.10 (d, J = 
7.7 Hz, 1H, (C5)-H), 5.73 (dd, J = 5.5, 5.1 Hz, 1H, (C2′)-H), 5.45 (dd, J = 5.1, 3.7 Hz, 
1H, (C3′)-H), 4.75-4.80 (m, 1H, (C4′)-H, partially obscured by HOD signal); 4.04 
(ABXY, J = 11.7, 5.7, 2.9 Hz, 1H, (C5′)-H), 3.95 (ABXY, J = 11.7, 5.7, 3.4 Hz, 1H, 
(C5′′)-H), 2.01 (s, 3 H, (C3′)-OAc), 1.93 (s, 3 H, (C2′)-OAc). 13C NMR (151 MHz, D2O) 
δ 173.3 (3′-OAc), 172.5 (2′-OAc), 167.0 (C4); 158.1 (C2), 142.8 (C6), 95.7 (C5), 85.6 
(C1′), 83.4 (d, C4′), 72.8 (C3′), 71.4 (C2′), 64.4 (d, C5′), 20.6 (OAc), 20.3 (OAc). 31P 
NMR (162 MHz, D2O, 1H-decoupled) δ 3.92. IR (neat; cm-1) 1742, 1642, 1484, 1213. 




Starting from β-ribo-4 (free acid, 160 mg, 0.50 mmol), yield = 172 mg (85%) as a white 
powder. 1H NMR (600 MHz, D2O) δ 8.08 (d, J = 7.9 Hz, 1H, (C6)-H), 6.22 (d, J = 7.9 
Hz, 1H, (C5)-H), 6.11 (d, J = 5.1 Hz, 1H, (C1′)-H), 5.41 (dd, J = 5.4, 5.1 Hz, 1H, (C2′)-
H), 5.38 (dd, J = 5.4, 4.3 Hz, 1H, (C3′)-H), 4.48 (ddd, J = 4.9, 4.3, 2.4 Hz, 1H, (C4′)-H), 
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4.13 (ABXY, J = 11.9, 4.4, 2.4 Hz, 1H, (C5′)-H), 4.02 (ABXY, J = 11.9, 4.9, 2.4 Hz, 1H, 
(C5′′)-H), 2.09 (s, 3H, (C3′)-OAc), 2.05 (s, 3H, (C2′)-OAc). 13C NMR (151 MHz, D2O) 
δ 173.4 (3′-OAc), 173.1 (2′-OAc), 160.7 (C4), 150.1 (C2), 144.3 (C6), 96.5 (C5), 88.2 
(C1′), 82.5 (d, C4′), 74.5 (C2′), 71.5 (C3′), 64.4 (d, C5′), 20.6 (3′-OAc), 20.5 (2′-OAc). 
31P NMR (162 MHz, D2O, 1H-decoupled) δ 0.30. HRMS (ESI) (m/z): [M+H+] calcd. for 
formula C13H19N3O10P, 408.0803; found, 408.0810. 




Starting from β-arabino-4 (free acid, 120 mg, 0.37 mmol), yield = 99 mg (66%) as a white 
solid.  = +82.8 (c 0.5, H2O); 1H NMR (600 MHz, D2O) δ 7.83 (d, J = 7.6 Hz, 1H, 
(C6)-H), 6.28 (d, J = 4.4 Hz, 1H, (C1′)-H), 5.99 (d, J = 7.6 Hz, 1H, (C5)-H), 5.42 (dd, J 
= 4.4, 2.2 Hz, 1H, (C2′)-H), 5.21 (dd, J = 3.5, 2.2 Hz, 1H, (C3′)-H), 4.30 - 4.36 (m, 1H, 
(C4′)-H), 4.07–4.13 (m, 1H, (C5′)-H), 4.00–4.07 (m, 1H, (C5′′)-H), 2.08 (s, 3H, (C3′)-
OAc), 1.92 (s, 3H, (C2′)-OAc). 13C NMR (151 MHz, D2O) δ 173.5 (3′-OAc), 172.4 (2′-
OAc), 166.5 (C4), 157.2 (C2), 143.1 (C6), 96.2 (C5), 85.7 (C1′), 81.5 (d, C4′), 76.7 (C3′), 
75.3 (C2′), 64.4 (d, C5′), 20.9 (3′-OAc), 20.4 (2′-OAc). 31P NMR (162 MHz, D2O, 1H-
decoupled) δ 0.68. IR (neat, cm-1) 1745, 1650, 1485, 1429, 1373, 1233, 1054. HRMS 
(ESI) (m/z): [M+H+] calcd. for formula C13H19N3O10P, 408.0803; found, 408.0810. 
 




Nucleosides (100mM) and N-acetyl imidazole (10 eq.) were dissolved in water and the 
solution was adjusted to pH 8 by addition of 4M NaOH. The reaction mixture was left 
standing for 4 h at r.t., and then lyophilized. The residue was purified by C18 column 





Starting from α-ribo-10 (240 mg, 1.0 mmol), yield = 236 mg (65%) as a white powder. 
= -39.8 (c 1.0, H2O). 1H NMR (600 MHz, D2O) δ 7.73 (d, J = 7.6 Hz, 1H, (C6)-H), 
6.33 (d, J = 5.0 Hz, 1H, (C1′)-H), 6.00 (d, J = 7.6 Hz, 1H, (C5)-H), 5.69 (t, J = 5.0 Hz, 
1H, (C2′)-H), 5.42 (t, J = 5.0 Hz, 1H, (C3′)-H), 4.71 - 4.78 (m, 1H, (C4′)-H, partially 
obscure by HOD signal), 4.33 (ABX, J = 12.3, 3.0 Hz, 1H, (C5′)-H), 4.21 (ABX, J = 
12.3, 4.4 Hz, 1H, (C5′′)-H), 2.09 (s, 3H, (C5′)-OAc), 2.01 (s, 3H, (C3′)-OAc), 1.93 (s, 
3H, (C2′)-OAc). 13C NMR (151 MHz, D2O) δ 174.4 (5′-OAc), 173.1 (3′-OAc), 172.4 (2′-
OAc), 166.6 (C4), 157.5 (C2), 142.6 (C6), 95. 9 (C5), 85.7 (C1′), 80.6 (C4′), 71. 8 (C3′), 
71.2 (C2′), 64.2 (C5′), 20.8 (OAc), 20.5 (OAc), 20.2 (OAc). 
 
2',3',5'-Tris-O-acetyl-β-cytidine (β-ribo-11) 
Starting from α-ribo-10 (120 mg, 0.5 mmol), yield = 141 mg (77%) as a white powder. 
1H NMR (600 MHz, D2O) δ 7.59 (d, J = 7.5 Hz, 1H, (C6)-H), 5.97 (d, J = 7.5 Hz, 1H, 
(C5)-H), 5.93 (d, J = 4.5 Hz, 1H, (C1′)-H), 5.43 (dd, J = 5.7, 4.5 Hz, 1H, (C2′)-H), 5.35 
(dd, J = 5.9, 5.7 Hz, 1H, (C3′)-H), 4.41–4.47 (m, 1H, (C4′)-H), 4.35 (ABX, J = 12.5, 2.9 
Hz, 1H, (C5′)-H), 4.30 (ABX, J = 12.5, 4.4 Hz, 1H, (C5′′)-H), 2.08 (s, 3H, (C3′)-OAc), 
2.07 (s, 3H, (C5′)-OAc), 2.06 (s, 3H, (C2′)-OAc). 13C NMR (151 MHz, D2O) δ 174.3 
(OAc), 173.3 (OAc), 173.2 (OAc), 166.9 (C4), 157.7 (C2), 142.6 (C6), 97.1 (C5), 90.0 
(C1′), 79.9 (C4′), 74.2 (C2′), 70.9 (C3′), 63.8 (C5′), 20.8 (OAc), 20.6 (OAc), 20.5 (OAc). 
The spectroscopic properties of this compound were consistent with the data reported in 
the literature.4 
 




α-Cytidine-5'-phosphate (α-ribo-4, 300 mg, 0.93 mmol) was dissolved in water (200 µL) 
and added dropwise to stirred pyridine/acetic anhydride (1:1, 10 mL) at r.t. After 3 d the 
solution was evaporated in vacuo by co-evaporation with toluene (10 mL). The residue 
was dissolved in pyridine/water (1:5, 12 mL), stirred for 2 h at r.t. and concentrated in 
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vacuo. The residue was purified by reverse phase (C18) column chromatography (100mM 
NH4HCO2 (pH 4)/MeCN 98:2 to 0:1) to afford N4-acetyl-2',3'-di-O-acetyl-α-cytidine-5'-
phosphate (α-ribo-8, 259 mg, 62%) as a white powder.  
M. p. 174–179 °C (decomp.). 1H NMR (600 MHz, D2O) δ 8.21 (d, J = 7.6 Hz, 1H, (C6)-
H), 7.33 (d, J = 7.6 Hz, 1H, (C5)-H), 6.39 (d, J = 5.5 Hz, 1H, (C1′)-H), 5.79 (dd, J = 5.5, 
5.2 Hz, 1H, (C2′)-H), 5.46 (dd, J = 5.2, 3.6 Hz, 1H, (C3′)-H), 4.75–4.80 (m, 1H, (C4′)-H, 
partially obscured by HOD signal), 4.06 (ABXY, J = 11.7, 5.5, 3.0 Hz, 1H, (C5′)-H), 
3.98 (ABXY, J = 11.7, 5.5, 3.4 Hz, 1H, (C5′′)-H), 2.17 (s, 3H, NHAc); 1.97 (s, 3H, (C3′)-
OAc), 1.87 (s, 3H, (C2′)-OAc). 13C NMR (151 MHz, D2O) δ 174.8 (NHAc), 173.1 (3′-
OAc), 172.3 (2′-OAc), 163.5 (C4), 157.37 (C2), 146.9 (C6). 97.9 (C5), 86.5 (C1′), 83.3 
(d, C4′), 72.4 (C3′), 71.2 (C2′), 65.2 (d, C5′), 24.7 (NHAc), 20.5 (3′-OAc), 20.2 (2′-OAc). 
31P NMR (162 MHz, D2O, 1H-decoupled) δ 0.43. IR (cm-1) 1743, 1650, 1619, 1566, 1492, 
1223. HRMS (ESI) (m/z): [M+H+] calcd. for formula C15H21N3O11P, 450.0908; found, 
450.0910. 
 
Figure S4: 1H NMR spectrum (600 MHz, D2O, 1.5 – 9.0 ppm) to show the crude products 












General procedure for UV irradiation  
 
Nucleotides (2.5–5mM) were dissolved in water at pH 6.5, sparged with Ar or N2 (1 h) 
and irradiated continuously at 254 nm. A flow of water (through a quartz water-jacket 
between the lamp and solution) maintained the solution temperature (25–35 ºC) and the 
solution was continuously agitated by continuous Ar or N2 flow. After irradiation (O=254 
nm) the solution was allowed to stand at r.t. for 1 h and lyophilized. The lyophilite was 
dissolved in water and NMR spectra were acquired. The solution was then lyophilized. 
The lyophilite was dissolved in water (2 mL) and heated for 16 h at 90 °C to eliminate 
photohydrates.2,5–10 The solution was then lyophilized, the lyophilite was dissolved in 
D2O and analyzed by NMR in D2O. In the case of the acetylated nucleotides, the residue 
was lyophilized again and subsequently treated with NH4OH (28% in H2O, 2 mL) for 16 
h at r.t. Then, the reaction mixture was lyophilized and the residue analyzed by NMR. 
Yields were calculated by integration of H-(C6) for nucleotides, nucleosides and 
nucleobases and by integration of H-(C2') for oxazolidinones.  
 
Irradiation of free nucleotides 
 




Irradiation (O=254 nm) of α-ribocytidine-5′-phosphate (α-ribo-4, 2.5mM) for 16 h affords 
a mixture: α-ribocytidine-5′-phosphate (α-ribo-4, 17%), β-ribocytidine-5′-phosphate (β-
ribo-4, 5%), β-arabinocytidine-5′-phosphate (β-arabino-4, 5%), α-ribouridine-5′-
phosphate (α-ribo-9, 9%), β-ribouridine-5′-phosphate (β-ribo-9, 5%), β-arabinouridine-
5′-phosphate (β-arabino-9, 11%), ribose oxazolidinone-5'-phosphate (ribo-6, 22%), 





Figure S5. 1H NMR spectrum (400 MHz, D2O, 5.00–8.15 ppm) to show products of the 
irradiation (O=254 nm) of α-ribocytidine-5′-phosphate (α-ribo-4, 2.5mM) for 16 h 
followed by heating at 90 °C to eliminate uridine photohydrates. Cyt=cytosine; 
Ura=uracil. 
 





Table S1. Yields of products observed following the irradiation (O=254 nm) of free 
nucleotides (conc. = 5mM). 
Compound t 
(h) 
































































































Irradiation of acetylated nucleotides 
 




Table S2. Yields of products observed following the irradiation (O=254 nm) of 2',3'-di-





pH  Yield of photoproducts (%) 
β-ribo-4 β-ribo-9 α-ribo-4 α-ribo-9 Cyt + Ura ribo-6 
5 16 6.5 14 - 59 15 7 5 
5 24 6.5 10 tr. 36 26 21 7 
2.5 16 6.5 18 4 41 19 11 7 
2.5 24 6.5 9 6 35 31 18 11 
5 16 8.0 16 tr. 41 12 20 11 
2.5 16 8.0 17 tr. 49 15 11 8 
tr. = trace. 
 
Figure S6. 1H NMR spectrum (400 MHz, D2O, 5.00–8.15 ppm) to show the products of 
16 h irradiation (O=254 nm) of 2',3'-di-O-acetyl-α-cytidine-5'-phosphate (α-ribo-7, 
2.5mM) at: A) pH 6.5 and B) pH 8.0 followed by elimination of photohydrates and 
deacetylation with aqueous ammonia. Cyt=cytosine; Ura=uracil 
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Figure S7. 1H NMR spectra (400 MHz, D2O, 5.00–8.15 ppm) to show the products of 16 
h irradiation (O=254 nm) of 2',3'-di-O-acetyl-α-cytidine-5'-phosphate (α-ribo-7, 2.5mM) 
at pH 6.5 after: A) elimination of photohydrates and deacetylation with aqueous 
ammonia; B) spiking with β-ribo-4.  
 
 
Acetylation of α-ribo-4 followed by irradiation in one-pot protocol 
 
Nucleotide α-ribo-4 (100mM) and N-acetyl imidazole (10 eq.) were dissolved in water 
and the solution was adjusted to pH 8.0 by addition of 4M NaOH. The reaction mixture 
was left standing for 4 h at r.t., and then diluted to 2.5mM and readjusted to pH 8.0 by 
addition of 4M NaOH. The resulting solution was sparged with Ar (1 h) and irradiated for 
16 h at 254 nm as described above.  
 
Table S3. Yields of products observed following the acetylation then irradiation (O=254 
nm) of 2',3'-di-O-acetyl-α-cytidine-5'-phosphate (α-ribo-7, 2.5mM) for 16 h and 
deacetylation with aqueous ammonia. 
Conc. 
(mM) 
pH Yield of photoproducts (%) 
β-ribo-4 β-ribo-9 α-ribo-4 α-ribo-9 Cyt + Ura ribo-6 
2.5 8.0 11 tr. 57 10 13 9 





Figure S8. 1H NMR spectrum (700 MHz, D2O, 4.90–8.30 ppm) to show the products of: 
A) acetylation of α-ribo-4 (100mM) with N-acetyl imidazole (10 eq.) after 4 h in H2O at 
pH 8 (yield α-ribo-7: 87%, the rest are partially O-acetylated products); B) 16 h 
irradiation (O=254 nm) of the dilute crude mixture  (α-ribo-7, 2.5mM) at pH 8.0 followed 
by elimination of photohydrates and deacetylation with aqueous ammonia. Cyt=cytosine. 
 
Role of 5'-phosphate in the irradiation of α-ribo-7: Irradiation of acetylated α/β cytidines 




Table S4. Yields of products observed following the irradiation (O=254 nm) of 2',3',5'-
tri-O-acetyl-α-cytidine (α-ribo-11) or 2',3',5'-tri-O-acetyl-β-cytidine (β-ribo-11) and 





Yield of photoproducts (%) 
β-ribo-10 β-ribo-22 α-ribo-10 α-ribo-22 Cyt + Ura ribo-12 
α-ribo-11 10 16 2 0 74 17 2 5 
α-ribo-11 10 72 0 9 tr. 42 16 33 
α-ribo-11 + 
Pi[a] 
10 72 0 0 69 22 7 2 
β-ribo-11 10 16 57[b] 28[b] 2 0 3 tr. 





Figure S9: 1H NMR spectra (400 MHz, D2O, 3.50–8.00 ppm) to show the irradiation 
(O=254 nm) of α-cytidine-2',3',5'-tris-OAc (α-ribo-11) for: A) 16 h followed by 
elimination of photohydrates and deacetylation with aqueous ammonia; B) 72 h followed 
by elimination of photohydrates and deacetylation with aqueous ammonia; C) 72 h in the 
presence of phosphate buffer followed by elimination of photohydrates and deacetylation 
with aqueous ammonia. D) Spiking of spectrum C with β-ribo-10. E) Spiking of spectrum 














Irradiation (O=254 nm) of N4-acetyl-2',3'-di-O-acetyl-α-cytidine-5'-phosphate (α-ribo-
8). 
 
N-Acetylation was not observed under aqueous conditions, however to study the effect of 
pyrimidine N-acetylation on pyrimidine photoanomerization, solutions of α/β-ribo-8 
were irradiated at 10mM concentration.  
 
Table S5. Yields of products observed following the irradiation (O=245 nm) of 





Yield of photoproducts (%) 
β-ribo-4 β-ribo-9 α-ribo-4 α-ribo-9 Cyt + Ura rido-6 
α-ribo-8 10 16 tr. tr. 24 51 19 6 
α-ribo-8 10 72 - 9 18 9 61 3 





Figure S10. 1H NMR spectrum (400 MHz, D2O, 5.00–8.15 ppm) to show the products of 
16 h irradiation (O=254 nm) of N4-acetyl-2',3'-di-O-acetyl-α-cytidine-5'-phosphate (α-













Figure S11: 1H NMR spectrum (600 MHz, D2O, 1.5–9.0 ppm) to show α-ribo-7. 
 
Figure S12: 13C NMR spectrum (600 MHz, D2O, 0–200 ppm) to show α-ribo-7. 
 




Figure S14: 1H NMR spectrum (600 MHz, D2O, 1.5–9.0 ppm) to show α-ribo-11. 
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